The Biological Basis of Thrombosis and Bleeding in Patients with Ventricular Assist Devices
- 17 October 2008
- journal article
- review article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 2 (1) , 63-70
- https://doi.org/10.1007/s12265-008-9072-7
Abstract
The clinical success of left ventricular assist devices (LVADs) has been tempered by significant hemorrhagic and thromboembolic complications. In the case of LVADs, where the biomaterial is in direct contact with the blood circulation, significant changes in systemic immunologic and thrombostatic functions have been well documented. Although further investigation is warranted, significant advances have been made in both cellular biology and LVAD technology to better understand the delicate balance between the procoagulant milieu predisposing to thrombosis and the risks of both surgical and non-surgical bleeding.Keywords
This publication has 56 references indexed in Scilit:
- Midterm experience with the Jarvik 2000 axial flow left ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Cerebrovascular accidents in patients with a ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Hemodynamic Consequences of Thoracic Artificial Lung Attachment Configuration: A Computational ModelAsaio Journal, 2007
- Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2005
- Use of the Jarvik 2000 Left Ventricular Assist System as a Bridge to Heart Transplantation or as Destination Therapy for Patients With Chronic Heart FailureAnnals of Surgery, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant responseThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortalityThe Annals of Thoracic Surgery, 1995
- Microemboli during coronary artery bypass grafting: Genesis and effect on outcomeThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Prevalence and characteristics of intracranial microemboli signals in patients with different types of prosthetic cardiac valves.Stroke, 1994